Ending AIDS as a public health threat by 2030: Time to reset targets for 2025.

Acquired Immunodeficiency Syndrome / diagnosis Disease Eradication / economics Forecasting Global Health / economics Health Care Costs / trends Humans Public Health / economics Time Factors United Nations

Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
06 2021
Historique:
revised: 22 06 2021
pubmed: 9 6 2021
medline: 5 10 2021
entrez: 8 6 2021
Statut: epublish

Résumé

Paul De Lay and co-authors introduce a Collection on the design of targets for ending the AIDS epidemic.

Identifiants

DOI: 10.1371/journal.pmed.1003649 PMID: 34101728 PMC: PMC8219148
pubmed: 34101728
doi: 10.1371/journal.pmed.1003649
pii: PMEDICINE-D-21-02014
pmc: PMC8219148
doi:

Types de publication

Introductory Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003649

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIMH NIH HHS
ID : R25 MH067127
Pays : United States

Déclaration de conflit d'intérêts

All authors have declared that no competing interests exist.

Références

PLoS One. 2016 May 09;11(5):e0154893
pubmed: 27159260
Lancet. 2012 Jun 9;379(9832):2206-11
pubmed: 22682467
Lancet. 2011 Jun 11;377(9782):2031-41
pubmed: 21641026
PLoS Med. 2018 Oct 25;15(10):e1002678
pubmed: 30359372
Science. 2006 Mar 10;311(5766):1474-6
pubmed: 16456039
Science. 2001 Jun 29;292(5526):2434-6
pubmed: 11423619
J Int AIDS Soc. 2016 Dec 19;19(1):21348
pubmed: 27989271

Auteurs

Paul R De Lay (PR)

Independent Consultant, Washington, DC, United States of America.
ORCID: 0000-0003-4431-3327

Adèle Benzaken (A)

AIDS Healthcare Foundation, Manaus, Brazil.
ORCID: 0000-0002-1656-5749

Quarraisha Abdool Karim (QA)

Centre for AIDS Programme of Research in South Africa (CAPRISA), Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Mailman School of Public Health, Columbia University, New York, United States of America.
ORCID: 0000-0002-0985-477X

Sani Aliyu (S)

Department of Microbiology, Cambridge University Hospitals, United Kingdom.

Carolyn Amole (C)

Clinton Health Access Initiative, Boston, Massachusetts, United States of America.

George Ayala (G)

Alameda County Public Health Department, California, United States of America.
ORCID: 0000-0003-2255-7582

Kalipso Chalkidou (K)

Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, United Kingdom.
ORCID: 0000-0002-7087-2803

Judy Chang (J)

International Network of People Who Use Drugs (INPUD), London, United Kingdom.
ORCID: 0000-0002-4163-4048

Michaela Clayton (M)

Independent Consultant, Windhoek, Namibia.

Aleny Couto (A)

STI/HIV Program at Ministry of Health, Mozambique.

Carl Dieffenbach (C)

Division of AIDS, National Institute for AIDS and Infectious Disease (NIAID), Maryland, United States of America.
ORCID: 0000-0002-4929-7509

Mark Dybul (M)

Department of Medicine, Georgetown University, DC, United States of America.

Wafaa El Sadr (W)

ICAP, Columbia University, New York, United States of America.
ORCID: 0000-0003-3735-9781

Marelize Gorgens (M)

Health, Nutrition and Population Global Practice, World Bank Group, Washington, DC, United States of America.

Daniel Low-Beer (D)

World Health Organization, Geneva, Switzerland.
ORCID: 0000-0003-0042-0518

Smail Mesbah (S)

Algiers Faculty of Medicine, People's Democratic Republic of Algeria.

Jorge Saveedra (J)

AHF Global Public Health Institute, University of Miami, Florida, United States of America.
ORCID: 0000-0001-8974-7861

Petchsri Sirinirund (P)

Consultant, Bangkok, Thailand.

John Stover (J)

Avenir Health, Glastonbury, Connecticut, United States of America.
ORCID: 0000-0001-7236-1989

Omar Syarif (O)

The Global Network of People Living with HIV (GNP+), Zaandam, the Netherlands.

Aditia Taslim (A)

Independent Consultant (previously with Rumah Cemera), West Java, Indonesia.

Safiatou Thiam (S)

National AIDS Council, Dakar, Senegal.

Lucy Wanjiku Njenga (LW)

Positive Young Women Voices, New York, United States of America.

Peter D Ghys (PD)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Jose Antonio Izazola-Licea (JA)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
ORCID: 0000-0002-3658-2570

Luisa Frescura (L)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
ORCID: 0000-0002-2089-7818

Erik Lamontagne (E)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Peter Godfrey-Faussett (P)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
ORCID: 0000-0002-5929-9524

Christopher Fontaine (C)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.
ORCID: 0000-0001-5828-3291

Iris Semini (I)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Shannon Hader (S)

Joint UN Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › Syndrome d'immunodéficience acquise › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Éradication de maladie › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Sciences sociales › Prévision › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Coûts des soins de santé › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › Ending AIDS as a public health threat by 2030:...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Agences internationales › Nations Unies › Ending AIDS as a public health threat by 2030:...